JacobRotmenschMD

Obstetrics & Gynecology • Chicago, IL

Gynecologic Oncology

Professor of Obstetrics & Gynecology, Rush Medical College

Join to view full profile

Are you Dr. Rotmensch?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 72 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
5732 S Kenwood Ave
Chicago, IL 60637
Phone+1 773-909-4375

Summary

Dr. Jacob Rotmensch, MD is an obstetrician/gynecologist in Chicago, Illinois. He is currently licensed to practice medicine in Illinois, Indiana, and Maryland. He is affiliated with Insight Hospital and Medical Center, OSF Healthcare Little Company of Mary Medical Center, and Rush University Medical Center.

Education & Training

Johns Hopkins UniversityFellowship, Gynecologic Oncology, 1981 - 1984
Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 1977 - 1981
Meharry Medical CollegeClass of 1977

Certifications & Licensure

IL State Medical License 1984 - 2026
OH State Medical License 1977 - 2026
IN State Medical License 1992 - 2025
MD State Medical License 1981 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2004-2014
Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Chicago Magazine - Women's Health Castle Connolly, 2011
Top MD Consumers Checkbook
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Join now to see all

Clinical Trials

Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
Completed
Phase 2

Publications & Presentations

PubMed

2 citations
Mitigating ipatasertib-induced glucose increase through dose and meal timing modifications.
Dhruvitkumar S Sutaria, Priya Agarwal, Kuan-Chieh Huang, Dale R Miles, Jacob Rotmensch
Clinical and Translational Science. 2022-12-01
17 citations
Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study.
Erika Hamilton, Virginia G. Kaklamani, Carla I. Falkson, Gregory A. Vidal, Patrick J. Ward
Clinical Breast Cancer. 2021-05-15
2 citations
Somatic variants of potential clinical significance in the tumors of BRCA phenocopies.
Lela Buckingham, Rachel L Mitchell, Mark Maienschein-Cline, Stefan J. Green, Vincent Hong Hu
Hereditary Cancer in Clinical Practice. 2019-07-16

Professional Memberships